Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay-Reference-Cited by-同舟云学术

Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay

Published:2022-04 Issue:18 Volume:40 Page:2635-2646
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

LeBlanc Jason J.,ElSherif May,Ye Lingyun,MacKinnon-Cameron Donna,Ambrose Ardith,Hatchette Todd F.,Lang Amanda L.S.,Gillis Hayley D.,Martin Irene,Demczuk Walter H.B.,Andrew Melissa K.,Boivin Guy,Bowie William,Green Karen,Johnstone Jennie,Loeb Mark,McCarthy Anne E.,McGeer Allison,Semret Makeda,Trottier Sylvie,Valiquette Louis,Webster Duncan,McNeil Shelly A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference56 articles.

1. Detection and prediction of Streptococcus pneumoniae serotypes directly from nasopharyngeal swabs using PCR;Lang;J Med Microbiol,2015

2. Limited indirect effects of an infant pneumococcal vaccination program in an aging population;van der Linden;PLoS ONE,2019

3. Public Agency of Canada (PHAC). National laboratory surveillance of invasive streptococcal disease in Canada. Annual summary 2018. https://publications.gc.ca/collections/collection_2021/aspc-phac/HP57-4-2018-eng.pdf [last accessed Feb. 10, 2022].

4. Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010–2016;Demczuk;Vaccine,2018

5. Invasive pneumococcal disease in Canada 2010–2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines;Dion;Vaccine,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and economic burden of invasive pneumococcal disease and noninvasive all-cause pneumonia in hospitalized US adults: A multicenter analysis from 2015 to 2020;International Journal of Infectious Diseases;2024-06

2. Indirect impact of childhood 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian older adults: a Canadian Immunization Research Network (CIRN) retrospective observational study;Thorax;2024-02-15

3. Pneumococcal Vaccine Breakthrough and Failure in Infants and Children: A Narrative Review;Vaccines;2023-11-24

4. Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness;Open Forum Infectious Diseases;2023-06-13

5. Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13;Journal of Antimicrobial Chemotherapy;2023-05-03